Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals?

Author:

Epstein Rachel L1ORCID,Sperring Heather2,Hofman Melissa3,Lodi Sara4,White Laura F4,Barocas Joshua A1,Bouton Tara C1,Xiao Yian5,Hsu Heather E6,Miller Nancy S7,Linas Benjamin P1,Marathe Jai G1

Affiliation:

1. Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA

2. Center for Infectious Diseases, Boston Medical Center, Boston, Massachusetts, USA

3. Boston Medical Center, Boston, Massachusetts, USA

4. Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA

5. Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA

6. Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts, USA

7. Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA

Abstract

Abstract To determine the association between immunosuppression and time to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) clearance, we studied 3758 adults retested following initial SARS-CoV-2 infection. Cox proportional hazards models demonstrated delayed PCR clearance with older age, multiple comorbidities, and solid organ transplant but not by degree of immunocompromise. These findings challenge current retesting practices.

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Providence/Boston Center for AIDS Research

National Institute of General Medical Sciences

National Center for Advancing Translational Sciences

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3